Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
Di Veroli A, Campagna A, De Muro M, Maurillo L, Trawinska MM, LeonettiCrescenzi S, Petriccione L, Romano A, D'Addosio A, Cenfra A, Montanaro M, Felici S, Andriani A, Carmosino I, Niscola P, Montefusco E, Breccia M, Latagliata R.
Di Veroli A, et al. Among authors: petriccione l.
Leuk Res. 2019 Jan;76:65-69. doi: 10.1016/j.leukres.2018.11.012. Epub 2018 Dec 4.
Leuk Res. 2019.
PMID: 30578958